Skip to main content
SpringerLink
Log in
Book cover

Pathologie pp 353–363Cite as

Multiple Sklerose und verwandte Erkrankungen

  • Chapter

  • 5545 Accesses

Zusammenfassung

Es werden Klinik, Pathogenese, Pathologie und histologische Klassifikation der Multiplen Sklerose sowie Mechanismen der axonalen Schädigung, der oligodendroglialen Schädigung, der Remyelinisierung sowie Veränderungen in der sog. normal erscheinenden weißen Substanz beschrieben. Weiterhin werden verwandte Entmarkungskrankheiten dargestellt, wie die Marburg-Krankheit, Balos konzentrische Sklerose, die Neuromyelitis optica, Schilders diffuse Sklerose und die akute disseminierte Enzephalomyelitis (ADEM).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   359.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams RD, Kubik CS (1952) The morbid anatomy of demyelinative diseases. Am J Med 12: 510–546

    Article  PubMed  CAS  Google Scholar 

  2. Bálo J (1928) Leukoencephalitis periaxialis concentrica. Arch Neurol Psychiatry 19: 242–264

    Google Scholar 

  3. Bar-Or A (2008) The immunology of multiple sclerosis. Semin Neurol 28: 29–45

    Article  PubMed  Google Scholar 

  4. Barkhof F (2002) The clinico-pathological paradox in multiple sclerosis revisited. Curr Opin Neurol 15: 239–245

    Article  PubMed  Google Scholar 

  5. Bitsch A, Wegener C, da Costa C, Bunkowski S, Reimers CD, Prange HW, Brück W (1999) Lesion development in Marburg’s type of acute multiple sclerosis: from inflammation to demyelination. Mult Scler 5: 138–146

    PubMed  CAS  Google Scholar 

  6. Bjartmar C, Kinkel PR, Kidd G, Rudick RA, Trapp BD (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57: 1248–1252

    PubMed  CAS  Google Scholar 

  7. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ (2003) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62: 723–732

    PubMed  Google Scholar 

  8. Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H (1995) Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38: 788–796

    Article  PubMed  Google Scholar 

  9. Buntinx M, Stinissen P, Steels P, Ameloot M, Raus J (2002) Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions. Crit Rev Immunol 22: 391–424

    PubMed  CAS  Google Scholar 

  10. Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. New Engl J Med 346: 165–173

    Article  PubMed  Google Scholar 

  11. Charcot M (1868) Histologie de la sclérose en plaques. Gaz. Hopital (Paris) 41: 554–555

    Google Scholar 

  12. Chard D, Miller D (2009) Is multiple sclerosis a generalized disease of the central nervous system? An MRI perspective. Curr Opin Neurol 22: 214–218

    Article  PubMed  Google Scholar 

  13. Colucci M, Roccatagliata L, Capello E, Narciso E, Latronico N, Tabaton M, Mancardi GL (2004) The 14-3-3 protein in multiple sclerosis: a marker of disease severity. Mult Scler 10: 477–481

    Article  PubMed  CAS  Google Scholar 

  14. Compston A, Coles A (2002) Multiple sclerosis. Lancet 359: 1221–1231

    Article  PubMed  Google Scholar 

  15. Deber CM, Reynolds SJ (1991) Central nervous system myelin: structure, function, and pathology. Clin Biochem 24: 113–134

    Article  PubMed  CAS  Google Scholar 

  16. Devic C (1894) Myelite subaigue compliquee de nevrite optique. Bull Med 35: 18–30

    Google Scholar 

  17. Dreha-Kulaczewski SF, Helms G, Dechent P, Hofer S, Gartner J, Frahm J (2009) Serial proton MR spectroscopy and diffusion tensor imaging in infantile Balo’s concentric sclerosis. Neuroradiology 51: 113–121

    Article  PubMed  Google Scholar 

  18. Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7: 268–277

    Article  PubMed  Google Scholar 

  19. Fisher E, Lee JC, Nakamura K, Rudick RA (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64: 255–265

    Article  PubMed  Google Scholar 

  20. Ganter P, Prince C, Esiri MM (1999) Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 25: 459–467

    Article  PubMed  CAS  Google Scholar 

  21. Garell PC, Menezes AH, Baumbach G, Moore SA, Nelson G, Mathews K, Afifi AK (1998) Presentation, management and follow-up of Schilder’s disease. Pediatr Neurosurg 29: 86–91

    Article  PubMed  CAS  Google Scholar 

  22. Gault F (1894) De la neuromyélite optique aiguë. Lyon

    Google Scholar 

  23. Gilmore CP, Donaldson I, Bo L, Owens T, Lowe J, Evangelou N (2009) Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 80: 182–187

    Article  PubMed  CAS  Google Scholar 

  24. Goldschmidt T, Antel J, Konig FB, Bruck W, Kuhlmann T (2009) Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72: 1914–1921

    Article  PubMed  CAS  Google Scholar 

  25. Griffiths I, Klugmann M, Anderson T et al. (1998) Axonal swellings and degeneration in mice lacking the major proteolipidprotein of myelin. Science 280: 1610–1613

    Article  PubMed  CAS  Google Scholar 

  26. Hart MN, Earle KM (1975) Haemorrhagic and perivenous encephalitis: a clinico-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 38: 585–591

    Article  PubMed  CAS  Google Scholar 

  27. Hein T, Hopfenmüller W (2000) Hochrechnung der Zahl an Multiple Sklerose erkrankten Patienten in Deutschland. Nervenarzt 71: 288–294

    Article  PubMed  CAS  Google Scholar 

  28. Hu W, Lucchinetti CF (2009) The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol 31: 439–453

    Article  PubMed  CAS  Google Scholar 

  29. Hynson J, Kornberg A, Coleman L, Shield L, Harvey A, Kean M (2001) Clinical and neuroradiologic features of acute dissiminated encephalomyelitis in children. Neurology 22: 1308–1312

    Google Scholar 

  30. Jahn O, Tenzer S, Werner HB (2009) Myelin proteomics: molecular anatomy of an insulating sheath. Mol Neurobiol 40: 55–72

    Article  PubMed  CAS  Google Scholar 

  31. Jorens P, VanderBorght A, Ceulemans B et al. (2000) Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology 54: 1433–1441

    PubMed  CAS  Google Scholar 

  32. Karaarslan E, Altintas A, Senol U et al. (2001) Baló’s concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol 22: 1362–1367

    PubMed  CAS  Google Scholar 

  33. Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9: 520–532

    Article  PubMed  Google Scholar 

  34. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis. A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157: 267–276

    Article  PubMed  CAS  Google Scholar 

  35. Kuhlmann T (2009) Schädigungs- und Reparaturmechanismen in Multiple-Sklerose-Läsionen. Nervenheilkunde 28: 593–601

    Google Scholar 

  36. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125: 2202–2212

    Article  PubMed  Google Scholar 

  37. Kuhlmann T, Miron V, Cuo Q, Wegner C, Antel J, Bruck W (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131: 1749–1758

    Article  PubMed  CAS  Google Scholar 

  38. Kutzelnigg A, Faber-Rod JC, Bauer J et al. (2007) Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 17: 38–44

    Article  PubMed  Google Scholar 

  39. Kutzelnigg A, Lucchinetti CF, Stadelmann C et al. (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128: 2705–2712

    Article  PubMed  Google Scholar 

  40. Lassmann H, Raine CS, Antel J, Prineas JW (1998) Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 86: 213–217

    Article  PubMed  CAS  Google Scholar 

  41. Lennon VA, Wingerchuk DM, Kryzer TJ et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106–2112

    Article  PubMed  CAS  Google Scholar 

  42. Lublin FD (2003) Multiple sclerosis classification and overview. In: Lazzarini R (ed) Myelin biology and disorders. Elsevier, San Diego, pp 691–699

    Google Scholar 

  43. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122: 2279–2295

    Article  PubMed  Google Scholar 

  44. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707–717

    Article  PubMed  CAS  Google Scholar 

  45. Marburg O (1906) Die sogenannte akute Multiple Sklerose (Encephalomyelitis periaxialis scleroticans). Jahrb Psychiat Neurol 27: 213–312

    Google Scholar 

  46. Miyamoto N, Kagohashi M, Nishioka K et al. (2006) An autopsy case of Schilder’s variant of multiple sclerosis (Schilder’s disease). Eur Neurol 55: 103–107

    Article  PubMed  Google Scholar 

  47. Moore GR, Berry K, Oger JJ, Prout AJ, Graeb DA, Nugent RA (2001) Balo’s concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting dinical course. Mult Scler 7: 375–382

    PubMed  CAS  Google Scholar 

  48. Moore GR, Neumann PE, Suzuki K, Lijtmaer HN, Traugott U, Raine CS (1985) Balo’s concentric sclerosis: new observations on lesion development. Ann Neurol 17: 604–611

    Article  PubMed  CAS  Google Scholar 

  49. O’Riordan JI, Gallagher HL, Thompson AJ et al. (1997) Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60: 382–387

    Article  Google Scholar 

  50. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5: 932–936

    Article  PubMed  Google Scholar 

  51. Patrikios P, Stadelmann C, Kutzelnigg A et al. (2006) Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129: 3165–3172

    Article  PubMed  Google Scholar 

  52. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63: 964–968

    Article  PubMed  Google Scholar 

  53. Poser CM (1985) Myelinoclastic diffuse sclerosis. In: Koetsier JC (ed) Handbook of clinical neurology. Elsevier Science, Amsterdam, pp 419–428

    Google Scholar 

  54. Roemer S, Parisi JE, Lennon VA et al. (2007) Pattern-specific loss of auaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130: 1194–1205

    Article  PubMed  Google Scholar 

  55. Schirmer L, Albert M, Buss A, Schulz-Schaeffer WJ, Antel JP, Bruck W, Stadelmann C (2009) Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord. Ann Neurol 66: 698–704

    Article  PubMed  Google Scholar 

  56. Smestad C, Sandvik L, Landro NI, Celius EG (2010) Cognitive impairment after three decades of multiple sclerosis. Eur J Neurol 17: 499–505

    Article  PubMed  CAS  Google Scholar 

  57. Sobel RA, Moore GRW (2008) Acute disseminated encephalomyelitis and related disorders. In: Love S, Louis DN, Ellison DW (eds) Greenfield’ neuropathology. Edward Arnold, London, pp 1580–1584

    Google Scholar 

  58. Sobel RA, Moore GRW (2008) Schilder’s disease (myelinoclastic diffuse sclerosis). In: Love S, Louis DN, Ellison DW (eds) Greenfield’s neuropathology. Edward Arnold, London, pp 1569–1570

    Google Scholar 

  59. Stadelmann C, Ludwin S, Tabira T et al. (2005) Tissue preconditioning may explain concentric lesions in balo’s type of multiple sclerosis. Brain 128: 979–987

    Article  PubMed  Google Scholar 

  60. Tartaglia MC, Narayanan S, De Stefano N et al. (2002) Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 249: 1382–1390

    Article  PubMed  CAS  Google Scholar 

  61. Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31: 247–269

    Article  PubMed  CAS  Google Scholar 

  62. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. New Engl J Med 338: 278–285

    Article  PubMed  CAS  Google Scholar 

  63. Vanderlugt CL, Miller SD (2002) Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2: 85–95

    Article  PubMed  CAS  Google Scholar 

  64. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM (2006) Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67: 960–967

    Article  PubMed  CAS  Google Scholar 

  65. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112 (Pt 1): 133–146

    Article  PubMed  Google Scholar 

  66. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805–815

    Article  PubMed  CAS  Google Scholar 

  67. Young NP, Weinshenker BG, Lucchinetti CF (2008) Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 28: 84–94

    Article  PubMed  Google Scholar 

  68. Zeis T, Probst A, Steck AJ, Stadelmann C, Bruck W, Schaeren-Wiemers N (2009) Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis. Brain Pathol 19: 459–466

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Neuropathologie, Universitätskrankenhaus Münster, Domagkstraße 19, 48149, Münster, Deutschland

    Tanja Kuhlmann

Authors
  1. Tanja Kuhlmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pathologie Konsultationszentrum für Pankreas- und Endokrine Tumore, TU München, Ismaninger Straße 22, 81675, München, Deutschland

    Günter Klöppel (Werkherausgeber) (Werkherausgeber)

  2. Zentrum Pathologie und Rechtsmedizin, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Straße 1, 30625, Hannover, Deutschland

    Hans H. Kreipe (Werkherausgeber) (Werkherausgeber)

  3. Institut für Pathologie, Kliniken der Landeshauptstadt, Ludwig-Erhard-Straße 100, 65199, Wiesbaden, Deutschland

    Wolfgang Remmele (Werkherausgeber) (Werkherausgeber)

  4. Institut für Neuropathologie, Universitätsklinikum Münster, Domagkstraße 19, 48149, Münster, Deutschland

    Werner Paulus (Bandherausgeber) (Bandherausgeber)

  5. Institut für Neuropathologie, Universitätsklinikum der Rheinisch-Westfälischen Technischen Hochschule (RWTH) Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland

    J. Michael Schröder (Bandherausgeber) (Bandherausgeber)

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kuhlmann, T. (2012). Multiple Sklerose und verwandte Erkrankungen. In: Klöppel, G., Kreipe, H., Remmele, W., Paulus, W., Schröder, J. (eds) Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02324-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-02324-8_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-02323-1

  • Online ISBN: 978-3-642-02324-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation